https://www.selleckchem.com/products/cpi-1205.html
When BMI exceeded 30kg/m , use of BGs and sodium-glucose cotransporter2 inhibitors increased, and use of sulfonylureas and DPP4is decreased. Although DPP4is were the most used OADs for patients with BMI 30kg/m , they were the third most prescribed OADs for patients with BMI 35kg/m after BGs and sodium-glucose cotransporter2 inhibitors . DPP4i usage was as high as that of BG in the analysis of Japanese type2 diabetes mellitus patients with relatively low BMI. This was considered to be a treatment option appropriate for the patho
Like
Comment
Share
